Financials

  • Market Capitalization 551.48 M
  • Employee 115
  • Founded 2019
  • CEO N/A
  • Website www.artivabio.com
  • Headquarter Delaware, United States
  • FIGI BBG00VPZJ0F9
  • Industry Biotechnologies
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
ratio cours/bénéfice
-2.93
ratio cours/chiffre d'affaires
593.22

Related tickers

#NomPrix24h %7 jours %1M %1 an %Cap Boursière7 Derniers Jours
2844
CABA
Cabaletta Bio, Inc. - Common Stock
3.30 USD+6.11%+3.12%+23.60%+122.97%559.50 M USD
2845
PROK
ProKidney Corp. - Class A Ordinary Shares
1.85 USD-2.12%+6.32%+20.13%-11.06%559.30 M USD
2860
ZURA
Zura Bio Limited - Class A Ordinary shares
5.65 USD+1.99%-7.83%+3.48%+176.96%541.43 M USD
2863
DRUG
Bright Minds Biosciences Inc. - common stock
70.84 USD-1.24%-11.16%-3.41%+80.25%540.92 M USD